News
CMND
0.8345
+28.38%
0.1845
Trump to sign order on psychedelic used for PTSD, CBS News says
TipRanks · 18h ago
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
TipRanks · 19h ago
Clearmind announces DSMB recommendation to continue CMND-100 trial
TipRanks · 19h ago
Clearmind Medicine's CMND-100 Trial Clears Safety Review For Alcohol Use Disorder
NASDAQ · 1d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 1d ago
Clearmind advances CMND-100 alcohol use disorder trial, raises dose to 160 mg
PUBT · 1d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 1d ago
Clearmind Medicine Announces That Its Independent Data And Safety Monitoring Board Has Completed Its Review And Issued A Positive Recommendation To Continue The Ongoing FDA-approved Phase I/IIa Clinical Trial Of CMND-100 For The Treatment Of Alcohol Use Disorder
Benzinga · 1d ago
Clearmind Medicine DSMB backs continuing CMND-100 Phase I/IIa AUD trial at 160 mg dose
PUBT · 1d ago
CLEARMIND MEDICINE INC - TO PROCEED TO FOURTH COHORT, INCREASE CMND-100 DOSE TO 160MG
Reuters · 1d ago
Clearmind Medicine prices $1.75 million convertible note conversion at $0.6 a share
PUBT · 1d ago
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial
Barchart · 2d ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2d ago
Clearmind Medicine issues $1.75 million convertible notes, raises $1.58 million cash
PUBT · 2d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2d ago
Crude Oil Falls Sharply; Wells Fargo Earnings Miss Views
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Bloom, J&J, CarMax
Reuters · 2d ago
Nasdaq Surges 200 Points; Citigroup Posts Upbeat Earnings
Benzinga · 2d ago
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere
Reuters · 2d ago
Morning Movers: Globalstar climbs following deal to be acquired by Amazon
TipRanks · 2d ago
More
Webull provides a variety of real-time CMND stock news. You can receive the latest news about Clearmind Medici through multiple platforms. This information may help you make smarter investment decisions.
About CMND
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.